BBLG
Bone Biologics·NASDAQ
--
--(--)
--
--(--)
1.23 / 10
Underperform
Scoring 1.23/10 technically, the instrument displays challenging technical structure. Positive contributions from no significant factors are diluted by negative influences from Marubozu White, Long Upper Shadow, and MACD Death Cross. Technical judgment: cautious.
Analysis Checks(0/3)
Long Upper Shadow
Score1/10
Win Rate33.33%
Hist. Signals75
Avg Return-4.56%
Score1/10
Win Rate33.33%
Hist. Signals75
Avg Return-4.56%
Marubozu White
Score1/10
Win Rate40.74%
Hist. Signals27
Avg Return-2.86%
Score1/10
Win Rate40.74%
Hist. Signals27
Avg Return-2.86%
MACD Death Cross
Score1.7/10
Win Rate42.86%
Hist. Signals7
Avg Return-3.39%
Score1.7/10
Win Rate42.86%
Hist. Signals7
Avg Return-3.39%
Long Upper Shadow
Score1/10
Win Rate33.33%
Hist. Signals75
Avg Return-4.56%
Score1/10
Win Rate33.33%
Hist. Signals75
Avg Return-4.56%
MACD Death Cross
Score1.7/10
Win Rate42.86%
Hist. Signals7
Avg Return-3.39%
Score1.7/10
Win Rate42.86%
Hist. Signals7
Avg Return-3.39%
Marubozu White
Score1/10
Win Rate40.74%
Hist. Signals27
Avg Return-2.86%
Score1/10
Win Rate40.74%
Hist. Signals27
Avg Return-2.86%
Technical Analysis of BBLG?
- BBLG presents a Underperform setup with a Technical Score of 1.23/10. Key technical indicators highlight an RSI of 32.30 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 1.70. Traders should monitor key support at 1.31 and resistance at 1.47.
